Wakely Paul E
Department of Pathology, The Ohio State University Wexner Medical Center, James Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA.
Cancer Cytopathol. 2022 Oct;130(10):783-799. doi: 10.1002/cncy.22600. Epub 2022 May 31.
Mucoepidermoid carcinoma (MEC) is the most common salivary gland (SG) malignancy. In this study, the author undertook analysis of a large collection of MEC cytologic cases.
Cytopathology files were searched for MEC cases with histopathologic confirmation. Fine-needle aspiration (FNA) smears used standard technique.
Seventy-six cases (63 patients [M:F = 1:1; age range, 23-87 years; mean age, 58 years]) met inclusion criteria. Aspirates were primary (54 [71%]), metastatic (18 [24%]), and locally recurrent (4 [5%]). FNA sites included parotid gland (49 [64%]), regional lymph nodes (11 [14%]), submandibular gland (5 [7%]), inner canthus of eye (2 [3%]), and lung (2 [3%]); and single specimens from palate, jaw, shoulder, paranasal sinus, floor of mouth, ear canal, and effusion. Cytologic diagnoses included MEC (30 cases [39%]), suspicious for MEC (16 [21%]), non-MEC carcinoma (9 [12%]), suspicious for malignancy (SM) (2 [3%], malignant (M) (1 [1%]), SG and/or suspicious SG neoplasm (7 [8%]), atypical (3 [5%]), nonneoplastic (5 [6%]), nondiagnostic (2 [3%]), and benign SG neoplasm (1 [1%]). A total of 26% of low-grade (LG) cases were diagnosed as malignant in contrast to 87% malignant in high-grade (HG) cases. Cytomorphology depended on tumor grade. LG MEC contained intra- and/or extra-cellular mucin and more uniform cell and/or nuclear morphology, whereas cytologic atypia, anisonucleosis, and keratotic cells were more typical of HG tumors.
A malignant (M) or suspicious for malignancy (SM) cytologic interpretation was made in 76% of mucoepidermoid carcinoma (MEC) cases. In contrast to high-grade MEC (97% identified as M/SM), only 59% of low-grade (LG) MEC cases were interpreted as such, illustrating the continued diagnostic challenge posed by LG MEC using fine-needle aspiration biopsy.
黏液表皮样癌(MEC)是最常见的涎腺恶性肿瘤。在本研究中,作者对大量MEC细胞学病例进行了分析。
在细胞病理学档案中查找经组织病理学证实的MEC病例。细针穿刺(FNA)涂片采用标准技术。
76例(63例患者[男:女 = 1:1;年龄范围23 - 87岁;平均年龄58岁])符合纳入标准。穿刺标本为原发性(54例[71%])、转移性(18例[24%])和局部复发性(4例[5%])。FNA部位包括腮腺(49例[64%])、区域淋巴结(11例[14%])、下颌下腺(5例[7%])、内眦(2例[3%])和肺(2例[3%]);以及来自腭部、颌部、肩部、鼻旁窦、口腔底部、耳道和积液的单个标本。细胞学诊断包括MEC(30例[39%])、可疑MEC(16例[21%])、非MEC癌(9例[12%])、可疑恶性(SM)(2例[3%])、恶性(M)(1例[1%])、涎腺和/或可疑涎腺肿瘤(7例[8%])、非典型(3例[5%])、非肿瘤性(5例[6%])、无法诊断(2例[3%])和涎腺良性肿瘤(1例[1%])。低级别(LG)病例中26%被诊断为恶性,而高级别(HG)病例中87%为恶性。细胞形态学取决于肿瘤级别。LG MEC含有细胞内和/或细胞外黏液,细胞和/或核形态更均匀,而细胞学异型性、核大小不一和角化细胞在HG肿瘤中更典型。
76%的黏液表皮样癌(MEC)病例细胞学诊断为恶性(M)或可疑恶性(SM)。与高级别MEC(97%被鉴定为M/SM)相比,只有59%的低级别(LG)MEC病例被如此诊断,这说明使用细针穿刺活检诊断LG MEC仍然具有挑战性。